通过转录学和生物信息学揭示免疫透的特征,通过转录学和生物信息学来表征高伤心肌病中的基因
Jianmin Gong1,2, Bo Shi1,3, Ping Yang1
1Department of Clinical Laboratory, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, 210000, People's Republic of China.
Journal of inflammation research
|May 22, 2024
概括
这项研究确定了缩性心肌病 (HCM) 中的关键基因和免疫细胞变化. 这些发现突出了管理这种遗传性心脏病的潜在治疗点.
科学领域:
- 心血管疾病研究研究
- 免疫信息学是指免疫信息学.
- 基因组分析 基因组分析
背景情况:
- 增高性心肌病变 (HCM) 是一种遗传性心脏病,免疫关联不清楚.
- 了解免疫细胞的作用对于开发有效的HCM治疗至关重要.
研究的目的:
- 确定与HCM相关的候选基因和免疫细胞概况.
- 探索涉及HCM发展的潜在致病途径.
主要方法:
- 对GSE32453数据集的差异基因表达分析.
- 基因本体学和通路丰富分析 (DAVID,GSEA).
- 蛋白质与蛋白质相互作用网络的构建 (String,Cytoscape).
- 免疫细胞透分析 (CIBERSORT) 和诊断价值评估 (对GSE36961的ROC分析).
- 使用HPA数据库数据进行qRT-PCR验证.
主要成果:
- 在HCM中确定了254个上调和181个下调的基因.
- 突出的炎症信号通路 (MAPK,PI3K-Akt) 和心肌收缩通路.
- 在HCM患者中发现巨细胞,NK细胞和单细胞的透增加.
- 八个关键基因 (FOS,CD86,CD68,BDNF,PIK3R1,PLEK,RAC2,CCL2) 显示出诊断值 (AUC>0.8) 的结果.
- 在心肌细胞和纤维细胞中验证了基因表达.
结论:
- 生物信息学分析确定了关键的基因,途径和免疫细胞,这些基因与HCM有关.
- 这些发现为HCM的临床干预提供了潜在的新型治疗点.
相关概念视频
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...


